Bourgier C, Azria D, Fenoglietto P, Riou O, Almaghrabi M-Y, Supiot S, Mornex F, Giraud P
Service de radiothérapie, institut régional du cancer de Montpellier, 208, rue des Apothicaires, parc euromédecine, 34298 Montpellier cedex 05, France; Inserm U896, 208, rue des Apothicaires, parc euromédecine, 34298 Montpellier cedex 05, France; U896, université Montpellier 1, 208, rue des Apothicaires, parc euromédecine, 34298 Montpellier cedex 05, France.
Service de radiothérapie, institut régional du cancer de Montpellier, 208, rue des Apothicaires, parc euromédecine, 34298 Montpellier cedex 05, France; Inserm U896, 208, rue des Apothicaires, parc euromédecine, 34298 Montpellier cedex 05, France; U896, université Montpellier 1, 208, rue des Apothicaires, parc euromédecine, 34298 Montpellier cedex 05, France.
Cancer Radiother. 2014 Jul-Aug;18(4):337-41. doi: 10.1016/j.canrad.2014.02.008. Epub 2014 May 1.
In stage IV cancers, locoregional management of primitive tumours as surgery and/or radiotherapy improved both progression-free survival and overall survival. Among metastatic cancer patients, some of them are considered as oligometastatic stage as they present few metastatic sites associated with low tumor aggressiveness. For those patients, metastatic local control, and therefore prolonged time to progression should be reached through local treatments as surgery and/or radiofrequency ablation and/or stereotactic radiotherapy. Here we propose a review of oligometastatic stage and results from extracranial stereotactic radiotherapy in terms of efficacy and tolerance.
在IV期癌症中，对原发肿瘤进行手术和/或放疗等局部区域治疗可改善无进展生存期和总生存期。在转移性癌症患者中，一些患者被认为处于寡转移阶段，因为他们的转移部位较少且肿瘤侵袭性较低。对于这些患者，应通过手术和/或射频消融和/或立体定向放疗等局部治疗实现转移灶的局部控制，从而延长疾病进展时间。在此，我们就寡转移阶段以及颅外立体定向放疗在疗效和耐受性方面的结果进行综述。
